TITLE

Continuous Infusion of β-Lactam Antibiotics

AUTHOR(S)
MacGowan, A.P.; Bowker, K.E.
PUB. DATE
November 1998
SOURCE
Clinical Pharmacokinetics;1998, Vol. 35 Issue 5, p391
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
There are considerable laboratory data and information from animal and continuous culture in vitro models to support continuous infusion therapy for penicillins and cephalosporins, but, as yet, the only existing clinical data relate to cephalosporins. Penicillins do not exert concentration-dependent killing in the therapeutic range but have a post-antibiotic effect (PAE) against Gram-positive cocci but not Gram-negative rods. Animal models indicate the time (T) during which the serum concentrations exceed the minimum inhibitory concentration (MIC) of the pathogen [T > MIC] determines outcomes. Pharmacokinetic studies in humans indicate that continuous infusion with penicillins is possible but there are no clinical data on efficacy. Cephalosporins have similar pharmacodynamic properties to penicillins; T > MIC determines outcome. Data related to ceftazidime indicate that the drug concentration at steady-state (C) should exceed the pathogen MIC by >1-fold and perhaps by 4- to 5-fold or more. Human pharmacokinetics of ceftazidime administered by continuous infusion to a wide variety of patient groups indicates that C of >20 mg/L can easily be achieved using conventional daily doses. Clinical data indicate increased effectiveness of a continuous regimen in neutropenic patients with Gram-negative infection. Furthermore cefuroxime administration by continuous infusion has resulted in lower doses and shorter course durations. Little is known of the pharmacodynamics of monobactams and there are few clinical data on continuous infusion therapy. Carbapenems have different pharmacodynamics to other β-lactams as they have concentration-dependent killing and a PAE with both Gram-positive and Gram-negative bacteria. While T > MIC has a role in determining outcomes, the proportion of the dosing interval for which serum drug concentrations should exceed the pathogen MIC is less than for other β-lactams. In vitro models have shown that continuous infusion is effective, as is less frequent dosing. There are few data on continuous infusion of carbapenems but some patients have been treated with once-daily dosing. Clinically, continuous infusion therapy with penicillins and cephalosporins should be considered in patients infected with susceptible Gram-negative rods not responding to conventional therapy. As an approximation, the same total daily dose should be given but a bolus intravenous injection should be give at the start of continuous infusion to ensure C is reached rapidly. The C may be difficult to predict and determination of serum drug concentrations may be indicated. Ideally, the C should be calculated based on the MIC of the potential pathogen and may be higher or lower than the C achieved by a conventional daily dose.
ACCESSION #
9523216

 

Related Articles

  • Appropriate Prescribing of Oral Beta-Lactam Antibiotics. Holten, Keith B. // American Family Physician;8/1/2000, Vol. 62 Issue 3, p611 

    Beta-lactam antibiotics include penicillins, cephalosporins and related compounds. As a group, these drugs are active against many gram-positive, gram-negative and anaerobic organisms. Information based on "expert opinion" and antimicrobial susceptibility testing supports certain antibiotic...

  • beta-lactam antibiotics. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p97 

    An encyclopedia entry for "beta-lactam antibiotics" is presented. It refers to a group of antibiotic drugs such as penicillins and the cephalosporins. These drugs work by altering chemical activity in bacteria thereby killing them.

  • The Fecal Microflora of 1-3-Month-Old Infants during Treatment with Eight Oral Antibiotics. Bennet, R.; Eriksson, M.; Nord, C. E. // Infection;Jun2002, Vol. 30 Issue 3, p158 

    We examined the fecal microflora of 1-3-month-oId infants during treatment with phenoxymethyl penicilIin, amoxycilIin, pivampicilIin, cefaclor, cefadroxil, Ioracarbef, erythromycin or cotrimoxazole. Escherichia coli increased during treatment with penicilIins or cephalosporins, but was not...

  • cephalosporin (Major drug group).  // Royal Society of Medicine: Medicines;2002, p147 

    The article presents information on cephalosporin, a group of antibiotic drugs that are chemically part of the beta-lactam class. They are broad-spectrum antibacterial drugs that act against both Gram-positive and Gram-negative bacteria. Their chemical structure bears a strong resemblance to...

  • Designing New �-Lactams: Implications from Their Targets, Resistance Factors and Synthesizing Enzymes. Kian-Sim Goo; Tiow-Suan Sim // Current Computer-Aided Drug Design;Mar2011, Vol. 7 Issue 1, p53 

    Penicillins and cephalosporins are ?-lactam antibiotics widely used to treat bacterial infectious diseases. They mainly target the cell wall biosynthesis pathway to inhibit bacterial growth. The targets, known as penicillin-binding proteins, are enzymes involved in the polymerization of glycan...

  • Nationwide hospital antibiotic consumption in Slovenia. Čižman, Milan // Journal of Antimicrobial Chemotherapy (JAC);Sep2011, Vol. 66 Issue 9, p2189 

    A letter about a survey of consumption of antibiotics in hospitals located in Slovenia is presented. The defined daily doses (DDD) and admissions in Slovenian hospitals are compared with those found in France. The antibiotics compared include imidazole derivatives, rifampicin, penicillin with...

  • β-Lactamases- the Threat Renews. Livermore, David M. // Current Protein & Peptide Science;Oct2009, Vol. 10 Issue 5, p397 

    β-Lactamases are the greatest single source of resistance to β-lactam antibiotics. For over 60 years, clinicians have seen a pattern whereby useful new β-lactam analogues are introduced but then select for new β-lactamases that cause resistance. Thus, penicillin G was undermined by...

  • When to use the newer beta-lactam antibiotics. Rosenfeld, Elaine; Shaughnessy, Allen F. // Patient Care;9/15/1995, Vol. 29 Issue 14, p119 

    Studies the use of the new beta-lactam antibiotics and some third generation cephalosporin drugs. Brief on the fungus Cephalosporium acremonium; Description of oral agents Cefixime, Cefpodoxime proxetil, Cefprozil and Loracarbef, and parental agents Ceftazidine, Aztreonam, Imipenem/cilastatin...

  • oxyimino beta lactam antibiotic.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1673 

    A definition of the term "oxyimino beta lactam antibiotic" is presented, which refers to a generation of cephalosporin.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics